FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment ...Middle East

Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy, according to data from three trials. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment )

Also on site :

• Kremlin comments on possible US strike on Iran
• Nazi symbols prevalent in Ukrainian military – Le Monde
• Israel’s war on Iran is not about nuclear weapons